Document:

CHANGE OF CONTROL AGREEMENT

CHANGE IN CONTROL AGREEMENT

THIS CHANGE IN CONTROL AGREEMENT (the "Agreement") is entered into as of June 15, 2006, (the "Effective Date"), by and between William Bracciodieta (the "Executive") and Molina Healthcare, Inc., a Delaware corporation (the "Company").

	Definitions.  The following definitions shall apply for all purposes under this Agreement:

	Change in Control.  "Change in Control" means the occurrence of any of the following events after the Effective Date:

	The acquisition (other than by an Excluded Person), directly or indirectly, in one or more transactions, by any person or by any group of persons, within the meaning of Section 13(d) or 14(d) of the Exchange Act, of beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) of more than fifty percent (50%) of either the outstanding shares of common stock or the combined voting power of the Company's outstanding voting securities entitled to vote generally, whether or not the acquisition was previously approved by the existing directors, other than an acquisition that complies with clause (x) and (y) of paragraph (ii);
	Consummation of a reorganization, merger, or consolidation of the Company or the sale or other disposition of all or substantially all of the Company's assets unless, immediately following such event, (x) all or substantially all of the stockholders of the Company immediately prior to such event own, directly or indirectly, more than fifty percent (50%) of the then outstanding voting securities of the resulting corporation (including without limitation, a corporation which as a result of such event owns the Company or all or substantially all of the Company's assets either directly or indirectly through one or more subsidiaries) and (y) the securities of the surviving or resulting corporation received or retained by the stockholders of the Company are publicly traded;
	Approval by the stockholders of the complete liquidation or dissolution of the Company; or
	A change in the composition of a majority of the directors on the Company's Board of Directors within 12 months if not approved by a majority of the pre-existing directors.

A transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Company's incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company's securities immediately before such transaction.

	Excluded Person.  "Excluded Person" means:

	Any person described in and satisfying the conditions of Rule 13d-1(b)(1) under the Exchange Act;
	The Company; 
	An employee benefit plan (or related trust) sponsored or maintained by the Company or its successor;
	Any person who is the beneficial owner (as defined in Rule 13d-3 under the Exchange Act) of more than 15% of the Common Stock on the Effective Date (or any affiliate, successor, heir, descendant, or related party of or to such person).

	Good Reason.  "Good Reason" shall mean that, on or after the effective date of a Change in Control, the Executive (without Executive's written consent):

	Has incurred a material reduction in his or her authority or responsibility in comparison to the Executive's authority or responsibility prior to the public announcement of the Change in Control (the "Announcement");
	Has incurred one or more reductions in his or her "total compensation" which is defined as follows:

	 any reduction in base salary, or
	 any reduction in the target annual bonus percentage of base salary; or

	Has been notified that his or her principal place of work will be relocated by a distance of 50 miles or more.

For purposes of this Agreement, "base salary" shall mean the Executive's annualized base salary as of the Effective Date, as may be subsequently adjusted upward for increases.

	Just Cause.  "Just Cause" includes but is not limited to any of the following committed by Executive (or omitted to be done by Executive) that occur on or after the Effective Date:

	Theft, unethical or unlawful activity, or other dishonesty;
	Neglect of or failure to perform employment duties;
	Inability or unwillingness to perform employment duties;
	Insubordination;
	Abuse of alcohol or other drugs or substances;
	Breach of this Agreement;
	A conviction of or plea of "guilty" or "no contest" to a felony under the laws of the United States or any state thereof; or 
	Any violation or breach of any Company policy that has been established to comply with either the Sarbanes-Oxley Act of 2002 (or any regulations or rules or decisions that implement/interpret such act) or any laws, rules, or requirements of the Securities and Exchange Commission or the New York Stock Exchange.

	Total Disability.  "Total Disability" shall be deemed to occur on the ninetieth (90th) consecutive or non-consecutive calendar day within any twelve (12) month period that Executive is unable to perform his or her duties because of any physical or mental illness or disability.

	Severance Payment and Equity Compensation.

	The Executive shall be entitled to receive a severance payment from the Company as provided herein (the "Severance Payment") if within the first twelve (12) month period after the occurrence of a Change in Control, either:

	The Executive voluntarily resigns his or her employment for Good Reason within sixty (60) days after the Executive becomes aware of the occurrence of an event specified in Section 1(c); or
	The Company terminates the Executive's employment for any reason other than Just Cause, death, or Total Disability.

For all purposes under this Agreement, the amount of the Severance Payment shall be equal to two times (2X) the Executive's annual base salary, as in effect on the date of the termination of Executive's employment (or if Executive's salary was greater, on the date of the Announcement), plus a prorata portion of the Executive's target bonus for the fiscal year in which Executive's employment is terminated, based on the number of entire months of such fiscal year that have elapsed through the date of Executive's termination of employment as a fraction of twelve (12).  The Severance Payment shall be made to Executive in a single lump sum cash payment not later than seven (7) business days following the date that Executive becomes entitled to a Severance Payment.

Except as may be provided under Sections 2(b) and 2(c), the Severance Payment shall be in lieu of any other post-termination employment payments.

	Incentive, Deferred Compensation, and Retirement Programs.  If the Executive is entitled to a Severance Payment under Section 2(a) and notwithstanding anything to the contrary in any stock option or stock appreciation right (SAR) or deferred compensation plan or retirement plan or agreements, then (i) the Executive shall become immediately fully vested in all of his or her outstanding stock options, SARs, warrants, restricted stock, phantom stock, deferred compensation, retirement or similar plans or agreements of the Company, and (ii) the Executive (or his or her personal representative if applicable) shall be permitted to exercise any of his or her vested stock options/SARs until the earlier of (i) one (1) year after Executive's termination of employment or (ii) the term of such unexercised stock options, warrants, or SARs.

	Health Coverage. If the Executive is entitled to a Severance Payment under Section 2(a), the Company shall reimburse Executive for a portion of the cost of any group health continuation coverage that the Company is otherwise required to offer under the Consolidated Omnibus Budget Reconciliation Act of 1986 ("COBRA") until the earlier of the date that (i) the Executive becomes covered by comparable health coverage, offered by another employer, or (ii) is twelve (12) months after the date upon which the Executive becomes entitled to a Severance Payment under Section 2(a).  The Executive shall continue to be responsible to pay for the cost of the employee portion of COBRA coverage (such employee portion cost shall not be reimbursed by the Company).

	Mitigation.  Except as may be expressly provided elsewhere in this Agreement, the Executive shall not be required to mitigate the amount of any payment or benefit contemplated by this Section 2 (whether by seeking new employment or in any other manner).  No such payment shall be reduced by earnings that the Executive may receive from any other source.

	Conditions.  All payments and benefits provided under this Section 2 are conditioned on Executive's continuing compliance with this Agreement and the Company's policies.  All payments and benefits are also conditioned on, and in consideration for, Executive's execution (and effectiveness) of a release of claims and covenant not to sue substantially in the form provided in Exhibit A upon termination of employment, to be delivered by Executive simultaneously upon payment by the Company.

	Successors.

	Company's Successors.  Any successor (whether direct or indirect and whether by purchase, lease, merger, consolidation, liquidation, or otherwise) to all or substantially all of the Company's business and/or assets, shall be obligated to perform this Agreement in the same manner and to the same extent as the Company would be required to perform it in the absence of a succession.

	Executive's Successors.  This Agreement and all rights of the Executive hereunder shall inure to the benefit of, and be enforceable by, the Executive's personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees, and legatees.

	Miscellaneous Provisions.

	Notice.  Notices and all other communications contemplated by this Agreement shall be in writing and shall be deemed to have been duly given when personally delivered or when mailed by U.S. registered or certified mail, return receipt requested and postage prepaid.  In the case of the Executive, mailed notices shall be addressed to him or her at the home address which he or she most recently communicated to the Company in writing.  In the case of the Company, mailed notices shall be addressed to its corporate headquarters, and all notices shall be directed to the attention of its Secretary.

	Waiver.  No provision of this Agreement shall be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by the Executive and by an authorized officer of the Company (other than the Executive).  No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time.

	Whole Agreement.  This Agreement contains all the legally binding understandings and agreements between Executive and the Company pertaining to the subject matter of this Agreement and supersedes all such agreements, whether oral or in writing, previously entered into between the parties.  

	Withholding Taxes.  All payments made under this Agreement shall be subject to reduction to reflect taxes required to be withheld by law.

	Choice of Law.  The validity, interpretation, construction, and performance of this Agreement shall be governed by the laws of the State of California without regard to the conflicts of laws principles thereof.

	Severability.  The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision hereof, which shall remain in full force and effect.

	Arbitration.  Any controversy or claim arising out of or relating to this Agreement, or the breach thereof, shall be settled by arbitration in Los Angeles County in accordance with the Commercial Arbitration Rules of the American Arbitration Association.  Discovery shall be permitted to the same extent as in a proceeding under the Federal Rules of Civil Procedure, including (without limitation) such discovery as is specifically authorized by section 1283.05 of the California Code of Civil Procedure, without need of prior leave of the arbitrator under section 1283.05(e) of such Code.  Judgment on the award rendered by the arbitrator may be entered in any court having jurisdiction thereof.  All fees and expenses of the arbitrator and such Association and attorney fees shall be paid as determined by the arbitrator.

	No Assignment.  The rights of Executive to payments or benefits under this Agreement shall not be made subject to option or assignment, either by voluntary or involuntary assignment or by operation of law, including (without limitation) bankruptcy, garnishment, attachment or other creditor's process, and any action in violation of this Subsection (h) shall be void.

	Nondisparagement; Confidentiality.  On the Effective Date and thereafter, Executive agrees that he/she will not disparage the Company or its directors, officers, employees, affiliates, subsidiaries, predecessors, successors or assigns in any written or oral communications to any third party.  Executive further agrees that he/she will not direct anyone to make any disparaging oral or written remarks to any third parties.  During Executive's employment and following Executive's termination of employment for any reason, Executive agrees to not intentionally use or disclose the confidential information or trade secrets of the Company.

	Nonsolicit.  During the Executive's employment with Company and for twelve months after Executive's termination of employment, the Executive shall not, directly or indirectly, either as an individual or as an employee, agent, consultant, advisor, independent contractor, general partner, officer, director, stockholder, investor, lender, or in any other capacity whatsoever, of any person, firm, corporation, or partnership: (i) induce or attempt to induce any person who at the time of such inducement is an employee of the Company to perform work or service for any other person or entity other than the Company or (ii) participate or engage in the design, development, manufacture, production, marketing, sale, or servicing of any product, or the provision of any service, that directly or indirectly relates to Company business.

	Notice of Employment.  During Executive's employment and for twelve months after Executive's termination of employment, Executive will promptly notify the Company in writing if Executive becomes (or agrees to become) an employee or director of any other employer.  Such notice shall include the name of the other employer and the date of commencement of employment or service as a director.

IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of the Company by its duly authorized officer, as of the day and year first above written.
EXECUTIVE:

/s/  William Bracciodieta

William Bracciodieta

MOLINA HEALTHCARE, INC.:

 

/s/  Joseph M. Molina

By:   Joseph M. Molina

Its:   President, CEO, and Chairman of the Board

EXHIBIT A

Form of Release of Claims and Covenant Not To Sue

In consideration of the payments and other benefits that Molina Healthcare, Inc., a Delaware corporation (the "Company"), is providing to William Bracciodieta ("Executive") under the Change in Control Agreement entered into by and between Executive and the Company, dated June 12, 2006, the Executive, on his or her own behalf and on behalf of Employee's representatives, agents, heirs and assigns, waives, releases, discharges and promises never to assert any and all claims, demands, actions, costs, rights, liabilities, damages or obligations of every kind and nature, whether known or unknown, suspected or unsuspected that Executive ever had, now have or might have as of the date of Executive's termination of employment with the Company against the Company or its predecessors, parent, affiliates, subsidiaries, stockholders, owners, directors, officers, employees, agents, attorneys, insurers, successors, or assigns (including all such persons or entities that have a current and/or former relationship with the Company) for any claims arising from or related to Executive's employment with the Company, its parent or any of its affiliates and subsidiaries and the termination of that employment.

These released claims also specifically include, but are not limited to, any claims arising under any federal, state and local statutory or common law, such as (as amended and as applicable) Title VII of the Civil Rights Act, the Age Discrimination in Employment Act, the Americans With Disabilities Act, the Employee Retirement Income Security Act, the Family Medical Leave Act, the Equal Pay Act, the Fair Labor Standards Act, the Industrial Welfare Commission's Orders, the California Fair Employment and Housing Act, the California Constitution, the California Government Code, the California Labor Code and any other federal, state or local constitution, law, regulation or ordinance governing the terms and conditions of employment or the termination of employment, and the law of contract and tort and any claim for attorneys' fees.

Furthermore, the Executive acknowledges that this waiver and release is knowing and voluntary and that the consideration given for this waiver and release is in addition to anything of value to which Executive was already entitled.  Executive acknowledges that there may exist facts or claims in addition to or different from those which are now known or believed by Executive to exist.  Nonetheless, this Agreement extends to all claims of every nature and kind whatsoever, whether known or unknown, suspected or unsuspected, past or present.  Executive also expressly waives the provisions of California Civil Code section 1542, which provides:  "A general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him/her must have materially affected his settlement with the debtor."  With respect to the claims released in the preceding sentences, the Executive will not initiate or maintain any legal or administrative action or proceeding of any kind against the Company or its predecessors, parent, affiliates, subsidiaries, stockholders, owners, directors, officers, employees, agents, successors, or assigns (including all such persons or entities that have a current or former relationship with the Company), for the purpose of obtaining any personal relief, nor assist or participate in any such proceedings, including any proceedings brought by any third parties (except as otherwise required or permitted by law).  The Executive further acknowledges that he has been advised by this writing that:

	he should consult with an attorney prior to executing this release;
	he has at least twenty-one (21) days within which to consider this release; 
	he has up to seven (7) days following the execution of this release by the parties to revoke the release; and 
	this release shall not be effective until such seven (7) day revocation period has expired.

Executive agrees that the release set forth above shall be and remain in effect in all respects as a complete general release as to the matters released.

EXECUTIVE

 

__________________________________

William Bracciodieta

Date:Agreement and General Release

 Exhibit 10.1 
 AGREEMENT AND GENERAL RELEASE 
 For good and valuable consideration, rendered to resolve and settle
finally, fully and completely all matters that now or may exist between them, the parties below enter this Agreement and General Release. 
 1. Parties. The parties to this Agreement are Jonathan R. Wolter, his heirs, representatives, successors and assigns (hereinafter referred to collectively as “Mr. Wolter”) and Neurobiological Technologies, Inc. and/or
any of its successors, subsidiaries, affiliates, parents, and related companies (hereinafter referred to collectively as “NTI”). 
 2. Termination of Employment. Mr. Wolter acknowledges and agrees that his employment relationship with NTI will end, effective June 15, 2006 (the “Termination Date”). Mr. Wolter shall continue to receive his
current salary and benefits up to and including the Termination Date. 
 3. Bonus. NTI shall pay Mr. Wolter a bonus equal to
$59,896, payable within 30 days after the Termination Date. 
 4. Computer equipment and cell phone. NTI shall provide to
Mr. Wolter the laptop computer, together with the directly-related peripheral devices, and the cell-phone that Mr. Wolter used during his period of employment at NTI. 
 5. Indemnification Agreement. NTI will indemnify Mr. Wolter and hold him harmless to the fullest extent allowable by law, from any claim,
demand or lawsuit, and any associated expenses, where the claim is made by any third party and arises from or relates to Mr. Wolter’s performance of his duties as an employee or officer of NTI. 
 6. Continued Medical Insurance. As consideration for the promises and covenants of Mr. Wolter set forth in this Agreement, NTI shall provide
Mr. Wolter with the following benefit. If Mr. Wolter makes a timely and accurate election and is and remains eligible to continue his current group medical insurance coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act
of 1985, as amended, (“COBRA”), NTI will pay the applicable premiums for Mr. Wolter and his eligible dependents to provide coverage for the six month period following the Termination Date. 
 7. Consultant Services. As consideration for the promises and covenants set forth in this Agreement, Mr. Wolter agrees to assist NTI as a
consultant providing consulting services relating to compliance with Section 404 of the Sarbanes-Oxley Act of 2002 and other financial reporting matters for the twelve month period following the Termination Date (the “Consulting
Period”). During the Consulting Period, Mr. Wolter agrees to provide assistance to NTI for up to 5 days per month, at mutually convenient times, as an independent contractor and not as an agent or an employee of NTI. As 

 
consideration for Mr. Wolter’s consultant services, NTI shall pay Mr. Wolter the sum of $10,416.67 per month. Mr. Wolter’s unvested
stock options will continue to vest during the Consulting Period in accordance with the terms of the Company’s 2003 Equity Incentive Plan (the “Plan”) and his stock option agreement, and those stock options vested as of the end of the
Consulting Period shall be exercisable until 90 days thereafter in accordance with the Plan. 
 8. Release of Claims by
Mr. Wolter. In exchange for the promises contained in this Agreement, Mr. Wolter hereby waives, releases and forever discharges, and agrees that he will not in any manner institute, prosecute or pursue, any and all complaints,
claims, charges, or causes of action, whether in law or in equity, which he asserts or could assert, at common law or under any statute, rule, regulation, order or law, whether federal, state, or local, or on any grounds whatsoever, including but
not limited to, any claims under Title VII of the 1964 Civil Rights Act, the Age Discrimination in Employment Act, the California Fair Employment and Housing Act, Government Code §12900 et seq., the California Labor Code, the
Americans with Disabilities Act, the California Family Leave Act, and the Employment Retirement Income Security Act of 1974, against NTI and any of its or their current or former, owners, shareholders, agents, employee benefit plans,
representatives, servants, employees, attorneys, successors, predecessors, and assigns (collectively referred to as “Released Parties”) with respect to any event, matter, claim, damage or injury arising out of Mr. Wolter’s
employment relationship with NTI, and the termination of such employment relationship, under or relating to any other agreement, express or implied, and with respect to any other claim, matter, or event arising prior to execution of this Agreement
by Mr. Wolter. 
 9. Release of Claims by NTI. In exchange for the promises contained in this Agreement, NTI hereby
waives, releases and forever discharges, and agrees that it will not in any manner institute, prosecute or pursue, any and all complaints, claims, charges, or causes of action, whether in law or in equity, which it asserts or could assert, at common
law or under any statute, rule, regulation, order or law, whether federal, state, or local, or on any grounds whatsoever, against Mr. Wolter with respect to any event, matter, claim, damage or injury arising out of Mr. Wolter’s
performance of his duties as an employee or officer of NTI, and the termination of such employment relationship, under or relating to any other agreement, express or implied, and with respect to any other claim, matter, or event arising prior to
execution of this Agreement by NTI. 
 10. Civil Code § 1542 Waiver. As a further consideration and inducement for this
Agreement, each party hereby waives any and all of its respective rights under Section 1542 of the California Civil Code or any similar state, local, or federal law, statute, rule, order or regulation it may have with respect to the other
party, and, in the case of Mr. Wolter, with respect to any of the Released Parties. 

 Section 1542 provides: 
 A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS
OR HER SETTLEMENT WITH THE DEBTOR. 
 Each party expressly agrees that this Agreement shall extend and apply to all unknown, unsuspected and
unanticipated injuries and damages as well as those that are now disclosed. 
 11. Outstanding Claims. As further consideration and
inducement for this Agreement, each party represents to the other that it has not filed or otherwise pursued any charges, complaints or claims of any nature which are in any way pending against the other party or, in the case of Mr. Wolter, any
of the Released Parties, with any local, state or federal government agency or court with respect to any matter covered by this Agreement and, to the extent permitted by law, neither party will do so in the future. If any government agency or court
assumes jurisdiction of any charge, complaint, cause of action or claim covered by this Agreement on behalf of one party against the other party or, in the case of Mr. Wolter, against any of the Released Parties, the party on whose behalf the
matter was assumed will withdraw from and/or dismiss the matter with prejudice, as to any claims that party might have. Each party agrees that it will not participate or cooperate in such matter(s) except as required by law. 
 12. Confidentiality Obligations. 
 (a) In the event that this Agreement is not made a matter of public record by NTI, Mr. Wolter agrees to maintain in confidence the terms of this Agreement and to discuss them only with his attorneys, tax advisors, and family
members who have a reasonable need to know of such terms. 
 (b) Mr. Wolter acknowledges and agrees that his obligations arising
under any and all confidentiality agreements between NTI and Mr. Wolter (the “Confidentiality Agreements”) shall remain in effect following his termination of employment, notwithstanding anything herein to the contrary. 
 13. Non-Disparagement. Mr. Wolter agrees to refrain from making any disparaging comments about NTI or any of the Released Parties. NTI agrees
to refrain, and agrees to cause its directors and officers to refrain, from making any disparaging comments about Mr. Wolter. For purposes of this Agreement, a disparaging comment is one that would likely cause material damage or harm to the
interests or reputation of NTI, Mr. Wolter or any of the Released Parties. 
 14. No Admission of Liability. By entering into
this Agreement, NTI and all Released Parties do not admit any liability whatsoever to Mr. Wolter or to any other 

 
person arising out of any claims heretofore or hereafter asserted by Mr. Wolter, and NTI, for itself and all Released Parties, expressly denies any and
all such liability. By entering into this Agreement, Mr. Wolter does not admit any liability whatsoever to NTI or to any other person arising out of any claims heretofore or hereafter asserted by NTI, and Mr. Wolter expressly denies any
and all such liability. 
 15. Joint Participation in Preparation of Agreement. The parties hereto participated jointly in the
negotiation and preparation of this Agreement, and each party has had the opportunity to obtain the advice of legal counsel and to review, comment upon, and redraft this Agreement. Accordingly, it is agreed that no rule of construction shall apply
against any party or in favor of any party. This Agreement shall be construed as if the parties jointly prepared this Agreement, and any uncertainty or ambiguity shall not be interpreted against any one party and in favor of the other. 

16. Attorneys’ Fees and Costs. As further mutual consideration of the promises set forth herein, NTI and Mr. Wolter agree that they
each are responsible for their own attorneys’ fees and costs. The parties agree that they will not seek from the other reimbursement for attorneys’ fees and/or costs relating to the negotiation of this Agreement or Mr. Wolter’s
termination of employment at NTI. 
 17. Governing Law. This Agreement is made and entered into in the State of California and
accordingly the rights and obligations of the parties hereunder shall in all respects be construed, interpreted, enforced and governed in accordance with the laws of the State of California as applied to contracts entered into by and between
residents of California to be wholly performed within California. 
 18. Section Headings. Section headings in this Agreement are
included for convenience of reference only and shall not be considered a part of this Agreement for any other purpose. 
 19. Scope of
Agreement. Mr. Wolter hereby affirms and acknowledges that he has read the foregoing Agreement, that he has had sufficient time and opportunity to review or discuss it with the counsel of his choice, and that he fully understands and
appreciates the meaning of each of its terms, and that it is a voluntary, full and final compromise, release and settlement of all claims, known or unknown, with respect to the claims identified and referred to herein. The parties to this Agreement
represent that this Agreement may be used as evidence in any subsequent proceeding in which any of the parties alleges a breach of this Agreement or seeks to enforce its terms, provisions or obligations. 
 20. Review and Revocation. Mr. Wolter expressly states that he has been given a period of at least 21 days within which to consider this
Agreement. Mr. Wolter is advised to consult with an attorney prior to signing this Agreement. This Agreement does not become effective until 7 days have passed after its execution by Mr. Wolter. 

 
Mr. Wolter understands that he may revoke this Agreement at any time during the 7 days following its execution by him. It is agreed that any such
revocation must be in writing and received by NTI within said 7 day period in order to be effective. 
 21. Entire Agreement. This
Agreement constitutes the complete understanding between Mr. Wolter and NTI and supersedes any and all prior agreements, promises, representations, or inducements, no matter its or their form, concerning its subject matter, with the exception
of any confidentiality, proprietary information or trade secret agreement signed by Mr. Wolter (including the Confidentiality Agreements), which remains in full force and effect to the extent not inconsistent with this Agreement. No promises or
agreements made subsequent to the execution of this Agreement by these parties shall be binding unless reduced to writing and signed by authorized representatives of these parties. Should any of the provisions of this Agreement be rendered invalid
by a court or government agency of competent jurisdiction, the remainder of this Agreement shall, to the fullest extent permitted by applicable law, remain in full force and effect. 
  

					
			
	 Dated: June 15, 2006
	 		 	 /s/ Jonathan R. Wolter

		 		 	 Jonathan R. Wolter

  

									
	 Dated: June 15, 2006
	 		 	 NEUROBIOLOGICAL TECHNOLOGIES, INC.

					
		 		 		 	 By:
	 	 /s/ Paul E. Freiman

		 		 		 		 	 Paul E. Freiman
 President & Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}]]